Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8888809

Download in:

View as

General Info

PMID
8888809